Treatment ofAchromobacterVentilator-Associated Pneumonia in Critically Ill Trauma Patients-Reference-Cited by-同舟云学术

Treatment ofAchromobacterVentilator-Associated Pneumonia in Critically Ill Trauma Patients

Published:2017-09-14 Issue:2 Volume:52 Page:120-125
ISSN:1060-0280
Container-title:Annals of Pharmacotherapy
language:en
Short-container-title:Ann Pharmacother

Author:

Wood G. Christopher¹,Jonap Brittany L.¹,Maish George O.¹,Magnotti Louis J.¹,Swanson Joseph M.¹,Boucher Bradley A.¹,Croce Martin A.¹,Fabian Timothy C.¹

Affiliation:

1. University of Tennessee Health Science Center, Memphis, TN, USA

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Link

http://journals.sagepub.com/doi/pdf/10.1177/1060028017730838

Reference40 articles.

1. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society

2. Achromobacter xylosoxidans Bacteremia: Report of Four Cases and Review of the Literature

3. Infections due to achromobacter xylosoxidans. Case report and review of the literature

4. Bacteremia Due to Achromobacter xylosoxidans in Patients with Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of acetylcysteine solution combined with fiberoptic bronchoscopy alveolar lavage in elderly patients with severe ventilator-associated pneumonia;Tropical Journal of Pharmaceutical Research;2022-01-26

2. Values of PCT and STREM-1 combined with clinical pulmonary infection score for the prognostic evaluation of elderly patients with ventilator-associated pneumonia;Revista Romana de Medicina de Laborator;2022-01-01

3. What is the role of Achromobacter species in patients with cystic fibrosis?;Frontiers in Bioscience-Landmark;2021-12-30

4. Trimethoprim-sulfamethoxazole as de-escalation in ventilator-associated pneumonia: a cohort study subanalysis;European Journal of Clinical Microbiology & Infectious Diseases;2021-02-24

5. An Overview of the Treatment of Less Common Non–Lactose‐Fermenting Gram‐Negative Bacteria;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2020-08-14